Avivagen Inc. announced earnings results for the full year ended October 31, 2018. For the full year, the company announced sales was CAD 1.072 million compared to CAD 255,660 a year ago. Net loss was CAD 4.834 million compared to CAD 5.045 million a year ago. Basic loss per share from continuing operations was CAD 0.15 compared to CAD 0.17 a year ago.